Shandong Weigao Group Medical Polymer Co 배당금이 안전한가요?
Shandong Weigao Group Medical Polymer Co은(는) 1년 동안 배당금을 증가시키고 있습니다.
지난 10년 동안 Shandong Weigao Group Medical Polymer Co의 연간 증가했습니다이 14.777% 증가했습니다하였습니다.
5년 간격으로 상승했다 배당금이 17.253% 증가했습니다.
분석가들은 현재 회계 연도에 4.272%의 배당금 증가를 예상하고 있습니다.
Shandong Weigao Group Medical Polymer Co Aktienanalyse
Shandong Weigao Group Medical Polymer Co는 무엇을 하나요?
Shandong Weigao Group Medical Polymer Co Ltd is a globally operating company with headquarters in Weihai, China. It was founded in 1988 and has been listed on the Hong Kong Stock Exchange since 2004.
The company specializes in the production of medical polymer products and offers a wide range of products for various applications. Its business model is that of an integrated platform for research, development, manufacturing, and marketing of medical devices. Their customers include hospitals, medical practices, and distributors worldwide.
The company's portfolio includes products in the areas of infusion, blood transfusion, dialysis, surgery, anesthesia, first aid, and diagnostics. Both disposable and reusable products are available. With its offering, the company aims to contribute to improving the quality of healthcare and providing better outcomes for patients.
Shandong Weigao Group Medical Polymer Co Ltd is divided into three divisions: Medical Devices, Medical Consumables, and Biology. The Medical Devices division manufactures devices for use in anesthesia, surgery, resuscitation, and diagnostics. The Medical Consumables division includes products such as syringes, catheters, infusion and transfusion devices, disposable gloves, and wound dressings. The Biology division specializes in the development, manufacturing, and marketing of biopharmaceutical products, such as insulin.
The company's history is characterized by rapid expansion and continuous growth. The focus on R&D has played an important role in this. Through the use of advanced technologies, the company has acquired a multitude of patents in both China and other countries.
The company places a strong emphasis on quality assurance and has implemented a comprehensive quality control system. In addition, it aims to minimize its environmental impact and therefore operates according to the latest environmental standards.
In recent years, the company has established an international presence and opened subsidiaries in Europe and the USA. This demonstrates the company's desire to grow internationally and offer its products in more and more countries.
In summary, Shandong Weigao Group Medical Polymer Co Ltd is an innovative company specializing in the production of medical polymer products and biopharmaceutical products. It offers a wide range of products and is committed to a comprehensive quality control system and sustainability. With its international presence, the company aims to continue growing and offer its products worldwide. Shandong Weigao Group Medical Polymer Co은 Eulerpool.com에서 가장 인기 있는 회사 중 하나입니다.주식 저축계획은 투자자가 장기적으로 자산을 쌓아가는 매력적인 방법을 제공합니다. 주요 장점 중 하나는 이른바 '비용 평균 효과'인데, 이는 정기적으로 일정 금액을 주식이나 주식 펀드에 투자함으로써 가격이 낮을 때 자동으로 더 많은 비율을, 가격이 높을 때는 적은 비율을 구매하게 되므로 시간이 지남에 따라 주식 당 평균 매입 가격을 낮출 수 있습니다. 또한 주식 저축계획은 소규모 투자자도 소액으로 비싼 주식에 접근할 수 있도록 해주며, 규칙적인 투자는 규율 있는 투자 전략을 촉진하고 충동적인 매수나 매도와 같은 감정적인 결정을 피하는 데 도움이 됩니다. 게다가 투자자는 주식의 잠재적인 가치 상승뿐만 아니라 배당금 분배로부터도 이익을 얻을 수 있으며, 이를 재투자함으로써 복리 효과를 증대시켜 투자 자본의 성장을 강화할 수 있습니다.